Production (Stage)
Turnstone Biologics Corp.
TSBX
$0.3329
-$0.0065-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -99.39% | -37.38% | |||
| Gross Profit | 99.39% | 37.38% | |||
| SG&A Expenses | 49.38% | -18.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.20% | -33.30% | |||
| Operating Income | 25.20% | 33.30% | |||
| Income Before Tax | 1.94% | 32.56% | |||
| Income Tax Expenses | -99.76% | 202.33% | |||
| Earnings from Continuing Operations | 8.28% | 24.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.28% | 24.42% | |||
| EBIT | 25.20% | 33.30% | |||
| EBITDA | 25.61% | 33.36% | |||
| EPS Basic | 8.60% | 24.50% | |||
| Normalized Basic EPS | 8.89% | 27.74% | |||
| EPS Diluted | 8.60% | 24.50% | |||
| Normalized Diluted EPS | 8.89% | 27.74% | |||
| Average Basic Shares Outstanding | 0.34% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||